Improving sepsis risk assessment using a two-stage transformer model

FHS
March 17, 2025
10:51 am

Sepsis, a life-threatening condition caused by the body’s dysregulated response to infection, remains a leading cause of mortality in ICUs worldwide.

Exploring new ways to improve treatment options for kidney cancer patients

A Medical University of South Carolina Hollings Cancer Center researcher is exploring new ways to improve treatment options for kidney cancer patients.

December 31, 2024

Pharmalittle: Pfizer prices Paxlovid at $1,400 for a five-day course; EMA warns of counterfeit Ozempic

Good morning, everyone, and how are you today? We are doing just fine, thank you, thanks to the sunny skies over the STAT nerve center,

October 19, 2023

Syndax enters funding agreement with Royalty Pharma for Niktimvo

Niktimvo, an anti-CSF-1R antibody, has received approval in the US for treating chronic GVHD. Credit: Andrei_R/Shutterstock. Syndax Pharmaceuticals has entered a synthetic royalty funding agreement

November 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.